References
1. Gres’ N.A., Guzik E.O. Hygienic aspects of the formation of elementalosis of excess aluminum in humans. Mikroelementy v meditsine [Microelements in Medicine]. 2015; 16 (2): 28-36. (in Russian)
2. Kvitkova L.V., Vinichenko D.S., Borodkina D.A., et al.The role of zinc deficiency in the development of cardiovascular complications in patients with diffuse toxic goiter. Klinicheskaya i eksperimental’naya tireoidologiya [Clinical and Experimental Thyroidology]. 2017; 13 (4): 30-9. (in Russian)
3. Avtsyn A.P., Zhavoronkov A.A. Human trace elements. Moscow: Medicine, 1991: 496 р. (in Russian)
4. Kudrin A.V., Gromova O.A. Trace elements in immunology and oncology. Moscow: GEOTAR, 2007: 543 p. (in Russian)
5. Kvitkova L.V., Vinichenko D.S., Borodkina D.A., et al. The role of copper in the development of cardiovascular pathology in patients with diffuse toxic goiter. Farmateka [Farmateka]. 2018; (11): 90-6. (in Russian)
6. Belmer S.V., Gasilina T.V. Trace elements and microelementoses and their importance in childhood. Voprosi v sovremennoi pediatrii [Questions of Modern Pediatrics]. 2008; 7 (6): 91-6. (in Russian)
7 Shabalina E.A., Fadeev V.V. Effects of selenium as part of the conservative treatment of Graves disease. Kliniko-eksperimental’naya tireoidologiya [Clinical and Experimental Thyroidology]. 2016; 12 (4): 16-30. (in Russian)
8. Wertenbruch T., Willenberg H., Sagert C., et al. Serum selenium levels in patients with remission and relapse of Graves disease. Medicinal Chemistry. 2007; 3 (3): 281-4.
9. Vinichenko D.S., Kvitkova L.V., Zinchuk S.F., et al. On the relationship of the development of diffuse toxic goiter of severe and moderate severity with the security of the body of zinc. Aspirant [Graduate Student]. 2016; 76 (3): 71-80. (in Russian)
10. Troshina E.A., Sviridenko N.Yu., Vanushko V.E., et al. Federal clinical guidelines for the diagnosis and treatment of thyrotoxicosis with diffuse goiter (diffuse toxic goiter, Graves-Bazedov’s disease). Problemy endokrinologii [Problems of Endocrinology]. 2014; 60 (6): 67-77. (in Russian)
11. Mareev V.Yu., Ageev F.T., Arutyunov G.P., et al. SEHF, RSC and RSMSIM national guidelines on CHF diagnostics and treatment (fourth revision). Journal serdechnaya nedostatochnost’ [Journal of Heart Failure]. 2013; 14 (7): 379-472. (in Russian)
12. Fefilova I.B. Antiage medicine. Contemporary encyclopedia. Moscow: Exmo, 2015: 345 р. (in Russian)
13. Guzik E.O., Gres’ E.A., Romanyuk A.G., et al. Method of hygienic assessment of the balance of chemical elements in children (regional trace element passport). Instruction for use. Ministry of health of the Republic of Belarus. 2012. (in Russian)
14. Lisitsyn E.P. Public Health and health care. Moscow: GEOTAR-Med, 2002: 220 р. (in Russian)
15. Vinichenko D.S. Selenium and zinc deficiency - risk factors for the formation of cardiovascular complications in patients with diffuse toxic goiter. Integrative medicine. 10 years to the journal "Politrauma": Materials of the XX Anniversary All-Russian scientific and practical conference. Leninsk-Kuznetsk; Kemerovo: Primula LLC; 2017: 239-40. (in Russian)
16. Borodkina D.A. Clinical and prognostic value of tissue distribution indicators and the nature of its distribution in patients with myocardial infarction with ST segment elevation: Abstract of Diss. Novosibirsk, 2016. (in Russian)
17. Onyeaghala A., Oduwole O., Ozoyiegbu R., et al. Trace elements it patients with thyrotoxicosis. Int J Appl Biol Farm Technol. 2011; 2 (2): 224-9.
18. Rybus-Kalinowska B., Zwirska-Korczala K., Kalinowski M., et al. Activity of antioxidative enzymes and concentration of malondialdehyde as oxidative status markers in women with newly diagnosed Graves-Basedow disease and after thiamazole therapy leading to euthyroidism. Pol Arch Med Wewn. 2008; 118 (7-8): 420-5.
19. Zhang F., Liu N., Wang X., et al. Study of trace elements in blood of thyroid disorder subjects before and after 131 I Therapy. Biol Trace Element Res. 2004; 2 (97): 33-40.
20. Abalovich M., Llesuy S., Gutierrez S., et al. Peripheral parameters of oxidative stress in Graves’ disease: the effects of methimazole and 131 iodine treatments. Clin Endocrinol (Oxf). 2003; 59 (3): 321-7.
21. Raygan F., Behnejad M., Ostadmohammadi V., et al. Selenium supplementation lowers insulin resistance and markers of cardio-metabolic risk in patients with congestive heart failure: a randomised, double-blind, placebo-controlled trial. Br J Nutr. 2018; 120 (120): 33-40.
22. Wu J.R., Song E.K., Moser D.K., et al. Racial differences in dietary antioxidant intake and cardiac event-free survival in patients with heart failure. Eur J Cardiovasc Nurs. 2018; 4 (17): 305-13.
23. Cohen N., Golik A. Zinc balance and medications commonly used in the management of heart failure. Heart Fail Rev. 2006; Vol. 11: 19-24.
24. Negreva M.N., Georgiev S.J., Penev A.P. Assessment of copper status in patients with paroxysmal atrial fibrillation. J Cardiobiol. 2014; 2 (2): 5.
25. Lima L.F., Barbosa F. Heart failure, micronutrient profile, and its connection with thyroid dysfunction and nutritional status. Clin Nutr. 2019; 38 (2): 800-5.